calprotectin

calprotectin

(kăl″prō-tĕk′tĭn)
A water-soluble, 36.5 kD protein found in the cytosol of neutrophils. Laboratory assays that detect fecal calprotectin (FC) are used as screening tests for colorectal cancer, diverticulitis, dysentery, and inflammatory bowel diseases. FC levels are not elevated in patients with functional or noninflammatory bowel disorders.
Mentioned in ?
References in periodicals archive ?
Both the frequency of liver cirrhosis (three of eight false-positive cases) and the use of aspirin or NSAIDs (four of eight false-positive cases) were significantly associated with false-positive calprotectin results (P = 0.
8 diagnostic device - Apparatus for the quantitative determination of calprotectin in stool - 1 set.
1 - reagents for tests performed by ELISA1 NGAL (lipokaina neutrophil gelatinase-associated) - one 000 tests2 Calprotectin in faeces-1000 TestTask No.
package 2 monitoring cardiac set - 1 set, 3 pack kit for the determination of calprotectin - 1 set package 4 set to ercp - 1 set, suite no.
Contract notice: Supply of the necessary products for the determination of biomarkers of heart failure, Sepsis and inflammation (nt-probnp, Procalcitonin, Calprotectin and ac citrullinated peptide) for the clinical analysis laboratory
M2 EQUITYBITES-January 4, 2018-Inova Diagnostics wins US FDA clearance for first fully automated, random access Calprotectin Test for IBD & IBS
M2 PHARMA-January 4, 2018-Inova Diagnostics wins US FDA clearance for first fully automated, random access Calprotectin Test for IBD & IBS
Biomarkers for instance C-reactive protein and fecal calprotectin are widely used to evaluate the inflammatory burden.
In reply to the difficulty of making an accurate diagnosis, several novel biomarkers, including serum amyloid A, riboleukograms, granulocyte colony stimulating factor (GCSF), calprotectin, and interleukin 6 have been studied in patients admitted with acute right lower-quadrant abdominal pain and AA.
Therefore, auxiliary assays, such as measurements of citrulline and calprotectin in the blood, cytofluorographic examination of peripheral blood immune cells, cytokine profiling, and distinct gene-set-change measurements, are increasingly being used in small bowel transplantation.
Smoking, prior intestinal resection, penetrating disease behavior, perianal disease, extensive bowel disease (>50 cm), preoperative corticosteroid use, postoperative immunomodulatory or biologic medical treatment, the presence of granulomas, myenteric plexitis, and fecal calprotectin have been found to be risk factors for POR (1,2,4,7-9).
A negative faecal calprotectin test combined with appropriate clinical assessment, offers a useful way of making a positive diagnosis of irritable bowel syndrome, without delay or resort to invasive and unpleasant investigation.